Airway Flow of RAM Cannula With BCPAP in Infants
Observational Study of Breathing and Flows in Bubble-CPAP Used With the RAM Cannula Interface in Newborn Infants
The RAM Cannula interface is used as routine interface for newborn infants receiving CPAP treatment for respiratory distress. Compared to the standard systems that have been used for more than 50 years, the interface has high resistance and has not been extensively studied. The delivered quality of the CPAP support is likely to be negatively affected by the interface resistance.
We hypothesise that exhalations through the device is uncommon and that the interface resistance restricts flow from the patient. If expiratory flows are uncommon the RAM interface provide support clinically comparable to other systems based on unidirectional flow such as humidified high-flow cannula.
This is a cross-sectional, observational study (no intervention) in newborn infants that are clinically stable and on respiratory support with the RAM interface connected to a bCPAP circuit. This is the most common support in the Phu San neonatal unit. The time needed for data collection is short and collection is expected to take approximately five minutes (less than 15 minutes) in a quiet infant. The collection can be planned to minimize disturbances for the infant, parents and staff. For example, the busiest times of the day can be avoided to not intervene with daily care, ward rounds or examinations of the infant.
Data on flow and pressure will be collected within the respiratory support circuit at the connection to the RAM interface. The measurements are passive, and no tests or manipulation of the infant is planned. There will be brief interruptions (<1 min) in respiratory support when the meters are connected. Similar interruptions are very common and occurs several times per day during normal care.
Data will be collected in case report forms (CRF) with REDCap electronic data capture tool. All personal identifiers will be removed before data export from REDCap and further analysis only using enrolment numbers.
Background variables describing the pregnancy, delivery and the infant will be collected. We also will record details of the RAM-cannula interface, such as size, protective dressing, gastric feeding tube, obvious leak at nares and mouth.
During the measurement the infant will be monitored for vital signs and any problems will be addressed and recorded. This includes oxygen need, CPAP support and breathing problems. The flow and pressure data for one minute of quiet breathing will be stored locally with the enrolment number as identifier. The analysis after collection of flow and pressure will include average flow in the CPAP circuit, the flow to the patient, average absolute leak and delivered pressure. If a variation with breathing can be seen this will be described. These output variables directly relate to the research questions.
- What flows and pressure can be observed in the breathing circuit? [Measured average flows, pressure and variability between patients]
- Do infants exhale through the RAM interface? [Measured expiratory flows at the interface]
- What is the level of leak for the interface? [Measured absolute leak]
The RAM cannula interface has been widely introduced but is not CE-marked for CPAP support. It has an advantage of being more comfortable and light weight with less nasal injury in most trials. The high resistance of the RAM interface has been discussed as problematic by several authors, but the clinical importance is not known. Comparing RAM interface to other CPAP interfaces in clinical trials is difficult and, if RAM has a treatment effect similar to HHFNC, very large trials of high quality would be needed.
The described study will generate new knowledge on the RAM interface by describing patient flow through the interface and illustrate the importance of resistance and leak. The study is not strictly a physiological study but investigate flow in an airway interface. The most likely outcome is that exhalation is uncommon, and this would support that the RAM interface has more similarities with HHFNC than conventional CPAP.
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Hien Vu, MD
- Phone Number: +84 904 999 455
- Email: hien.vu@ki.se
Study Contact Backup
- Name: Thomas Drevhammar, Ass. Prof. (Docent)
- Phone Number: +46-63-154979
- Email: thomas.drevhammar@ki.se
Study Locations
-
-
-
Hanoi, Vietnam, 118000
- Phu San Hanoi Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Admitted to Phu San Hanoi Hospital Neonatology Unit
- Support with bubble CPAP and RAM interface
- Quiet and stable spontaneous breathing
- Investigation team available
Exclusion Criteria:
- Problems with routine CPAP care
- Major congenital malformation
- Known syndrome or neuromuscular disease
- Circulatory instability with inotropes
- Oxygen need >50% or CPAP >10 cm H2O
- Surfactant given the last 6 hours or expected to be needed the next 6 hours
- Expected to need NIPPV or intubation within 6 hours
- Recently extubated (<24 h)
- Recent large surgical procedure (<5 days)
- Nasal wound or irritation that hurts or is at risk of worsening during study
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Infant treated with bubble CPAP and receiving blended air/oxygen
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Airway flow in RAM interface
Time Frame: 60 seconds
|
Average airway flow (L/min) in a quiet breathing infant
|
60 seconds
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pressure at Y-piece connector of RAM interface
Time Frame: 60 seconds
|
Average pressure (cm H2O) over 60 seconds in a quiet breathing infant
|
60 seconds
|
|
Fresh gas flow to Y-piece connector for RAM interface
Time Frame: 60 seconds
|
Average flow (L/min) over 60 seconds in a quiet breathing infant
|
60 seconds
|
|
Exhalation through Y-piece connector for RAM interface
Time Frame: 60 seconds
|
Number of breaths (ratio) with an expiratory flow of (duration >0.1 ms) over 60 seconds in a quiet breathing infant
|
60 seconds
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adverse events
Time Frame: 1 hour
|
Any adverse events during the measurement
|
1 hour
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1758 CN/PS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.